IDIBAPS participates in the development of a new chronic lymphocytic leukemia solution with SOPHiA GENETICS and Diagnóstica Longwood
The partnership aims to improve current characterization and research practices of this disease.
The partnership aims to improve current characterization and research practices of this disease.
ISO 9001 Quality Management System Requirements is the nationally and internationally recognized quality standard based on continuous process improve1
Next Wednesday, June 22, a meeting will be held to recount the diseases and present the clinical trials.
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and1
IDIBAPS is promoting different programs to facilitate professionals combining patient care with biomedical research or enjoying periods of intensive1
Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which they1
The award, granted by the Academy of Medical and Health Sciences of Catalonia and the Balearic Islands, recognizes Novials' research career in the fi1
Researchers from Hospital Clínic-IDIBAPS have participated in the work published by the journal Nature Medicine.
The IDIBAPS research group Pathogenesis of neuronal autoimmune diseases, led by Josep Dalmau, and the company EUROIMMUN Medizinische Labordiagnostika1
Aleix Prat is leading the research, which focuses on discovering new ways of diagnosing hormone receptor-positive breast cancer, as well as new thera1